AVTR
AVTR
NYSE · Life Sciences Tools & Services

Avantor Inc

$13.57
+0.39 (+2.92%)
As of Aug 7, 8:00 PM ET ·
Financial Highlights (FY 2026)
Revenue
6.51B
Net Income
-526,883,546
Gross Margin
32.6%
Profit Margin
-8.1%
Rev Growth
-4.5%
D/E Ratio
0.71
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 32.6% 32.6% 35.9% 35.9%
Operating Margin -3.8% -3.4% 11.3% 12.6%
Profit Margin -8.1% -7.7% 8.1% 7.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 6.51B 6.82B 4.75B 3.52B
Gross Profit 2.13B 2.23B 1.70B 1.26B
Operating Income -249,385,636 -234,924,714 534.96M 445.57M
Net Income -526,883,546 -496,331,579 383.77M 271.46M
Gross Margin 32.6% 32.6% 35.9% 35.9%
Operating Margin -3.8% -3.4% 11.3% 12.6%
Profit Margin -8.1% -7.7% 8.1% 7.7%
Rev Growth -4.5% -4.5% +1.6% -9.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 1.93B 1.93B 1.48B 1.29B
Total Equity 2.73B 2.73B 2.97B 3.21B
D/E Ratio 0.71 0.71 0.50 0.40
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -241,798,290 -240,431,626 752.65M 628.44M
Free Cash Flow 295.43M 210.66M